From $13,000 to $20 million: how a PCOS diagnosis and a pair of scissors built Xali Organics

The achievement is more remarkable given they sold their home to fund the business and have achieved this stellar growth without raising a cent of external capital or selling through a single retail partner.

The direct-to-consumer skincare company, founded in 2022, has sold nearly 400,000 units - including more than 190,000 of its hero Lash Serum - and remains fully founder-owned.

For Kasey Giarratana, the brand's origins trace back to a medical diagnosis rather than a business plan that has positioned Xali Organics in one of the most competitive consumer categories.

After being diagnosed with polycystic ovary syndrome (PCOS), a hormonal condition that affected her skin and hair, Giarratana was advised to eliminate conventional beauty products as a precaution.

So, she began developing alternatives for personal use - identifying a gap between consumer demand for “clean beauty” and the reality of ingredient transparency.

“That experience forced me to look at the industry differently,” says Giarratana.

“There was a clear disconnect between what brands were claiming and what products were actually delivering.”

What began as a personal remedy became the foundation of a company.

The couple launched Xali Organics with minimal capital and no industry connections, selling directly to consumers online.

Rather than also following a traditional beauty model reliant on influencer marketing, Xali prioritised product performance and direct consumer trust.

Central to Xali's growth has been a focus on ingredient-driven formulations, notably in the lash and hair growth category.

The brand’s lead products are formulated using clinically recognised actives such as peptides and collagen, designed to support natural growth pathways without compromising long-term skin or hair health.

 “One of the brand’s defining moments came through what we call the Lash Chop,” says Giarratana.

“My partner cut off my eyelashes on camera and I used the lash serum on just one eye for eight weeks to demonstrate product efficacy and varying growth rates.”

It may have been an unconventional marketing approach, but the Lash Chop built trust in what is widely regarded as a low-trust category.

Within nine months, the business scaled from less than $1,000 in monthly revenue to over $1 million per month.

The Xali Organics team has doubled since January, growing from five employees to 10, as the company builds out operational capacity to match demand.

Giarratana says the brand is now exploring international expansion and is currently investing in the infrastructure to support expected global demand.

Growth is also being driven by product launches across skincare, haircare and beauty.

The Lash Serum remains the company's bestseller, accounting for about half of all units sold.

Giarratana says the formulation avoids prostaglandin analogues, a class of ingredients commonly used in lash growth products that have been linked to side effects including eye discolouration.

Xali Organics has deliberately avoided the traditional beauty brand playbook by only selling directly to the consumer, a model that Giarratana says allows the brand to control pricing, customer experience and margins.

The model is centred on high-performing, non-toxic formulations, a direct relationship with customers and speed in product development and iteration.

Customer feedback has been critical to driving growth as the company creates products in response to consumer needs.

As consumer awareness increases, Giarratana believes the industry is moving beyond “clean beauty” as a marketing label and toward a more informed, results-driven standard.

“We’re seeing a shift where consumers are no longer taking claims at face value,” she says.

“They want to understand ingredients, outcomes and long-term impact - and we’re creating products that they can trust.”